Thirdly, although we showed that both tumor cells and immune cells exhibited an induced IFN response upon zotatifin treatment, we recognize that the source of ISGs in heterogeneous tumor tissues can only be fully deconvoluted with single-cell RNA sequencing and spatial transcriptomics. This evidence concerns the gene IFNA1 and neoplasm.